To A4D14.0033--22 consultation and testing of cytokine levels and cell activation in clinical samples

Ended Awarded Last action

Contract number
HHSN27200012
Awardee
Awarding agency
Obligated
$4,818,153

Award facts

Opportunity
Contract value 55% obligated
  • $4,818,153.46 Current, with exercised options
  • $8,784,601.46 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Baltimore, MD 21201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00016 -$148,150
Supplemental Agreement for work within scope P00015 $0
Supplemental Agreement for work within scope P00014 $0
Funding Only Action P00013 -$58,020
Other Administrative Action P00012 $0
Other Administrative Action P00011 · Vaccine and treatment evaluation unit (VTEU), UMB 1300022I, to HHSN27200012-FY.2015.A4D14.0033. The purpose of this modification is to extend the period of… $0
Funding Only Action P00010 · The purpose of this modification is to deobligate expired FY15 funds from D-3A, and D-4A, to partially replace those funds through a reobligation of FY21… -$482,723
Funding Only Action P00009 · The purpose of this modification is to extend and add funding to option 4A. $365,183
Funding Only Action P00008 · The purpose of this modification is to deobligate expiring FY15 funds from lines 1 - 3. -$83,428
Exercise an Option P00007 $1,374,317
Other Administrative Action P00006 $0
Exercise an Option P00005 · Vaccine treatment and evaluation units FY.2015.A4D14.0033 $442,431
Other Administrative Action P00004 $0
Funding Only Action 3 $48,391
Exercise an Option 2 $592,553
Other Administrative Action 1 · Vaccine treatment and evaluation units $0
Original award $2,767,600
Show all 17

About this award

Written by GovTribe AI ·

This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The $8,784,601.46 award is for consultation and testing of cytokine levels and cell activation in clinical samples, which supports the VACCINE TREATMENT EVALUATION UNITS (VTEUS) major program. The contract is a cost-no-fee type and does not have a set-aside designation. The University System of Maryland is the parent organization of the prime contractor, UMB. As a leading academic health and research institution, UMB has an extensive portfolio of federal contracts and grants to support its biomedical and clinical research activities.

Quick answers

Who was awarded contract HHSN27200012?

HHSN27200012 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 2, 2015.

How much is contract HHSN27200012 worth?

The government has obligated $4,818,153 on HHSN27200012. Its potential value, with all options, is $8,784,601.

Is contract HHSN27200012 an order under another contract?

Yes. HHSN27200012 is a delivery order under HHSN272201300022I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).

Was contract HHSN27200012 competed?

The extent of competition for HHSN27200012 was full and open competition. The government received 6 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login